SphK1-targeted miR-6784 inhibits functions of skin squamous cell carcinoma cells

Sphingosine kinase 1 (SphK1) is overexpressed in skin squamous cell carcinoma (SCC). It has emerged as a novel therapeutic oncotarget. The current study identified a novel SphK1-targeting microRNA, microRNA-6784 (miR-6784). Here, we show that miR-6784 is located at the cytoplasm of A431 skin SCC cells. It directly binds to SphK1 mRNA. Ectopic overexpression of miR-6784 inhibited SphK1 3'-untranslated region (UTR) luciferase activity and downregulated its expression. Moreover, miR-6784 overexpression caused ceramide accumulation in skin SCC cells. Functional studies in established (A431 and SCC9) and primary skin SCC cells revealed that miR-6784 overexpression inhibited cell viability, proliferation, migration, and invasion. It also simultaneously provoked apoptosis activation. Conversely, miR-6784 silencing by antagomiR-6784 induced SphK1 elevation and augmented A431 cell proliferation, migration, and invasion. miR-6784 overexpression-induced anti-A431 cell activity was inhibited by the expression of an UTR-null SphK1 construct. CRISPR/Cas9-induced SphK1 knockout inhibited A431 cell growth. Importantly, miR-6784 was completely ineffective when treating SphK1-knockout A431 cells. Collectively, miR-6784 silences SphK1 and inhibits skin SCC cell progression.

[1]  Chen Yao,et al.  The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells , 2020, Aging.

[2]  Youguo Chen,et al.  microRNA-1203 targets and silences cyclophilin D to protect human endometrial cells from oxygen and glucose deprivation-re-oxygenation , 2020, Aging.

[3]  G. Calin,et al.  MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. , 2019, Molecular aspects of medicine.

[4]  Q. Jiang,et al.  Targeting cullin 3 by miR-601 activates Nrf2 signaling to protect retinal pigment epithelium cells from hydrogen peroxide. , 2019, Biochemical and biophysical research communications.

[5]  Jin Yao,et al.  Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis , 2018, Theranostics.

[6]  Sai Zhang,et al.  CircNT5E Acts as a Sponge of miR-422a to Promote Glioblastoma Tumorigenesis. , 2018, Cancer research.

[7]  Guangyu Wu,et al.  IGF2BP1 over-expression in skin squamous cell carcinoma cells is essential for cell growth. , 2018, Biochemical and biophysical research communications.

[8]  E. Olasz,et al.  The microRNA landscape of cutaneous squamous cell carcinoma. , 2018, Drug discovery today.

[9]  Zheng-quan Yu,et al.  microRNA-200a downregulation in human glioma leads to Gαi1 over-expression, Akt activation, and cell proliferation , 2018, Oncogene.

[10]  N. Segami,et al.  Expression of Sphingosine Kinase-1 Is Associated with Invasiveness and Poor Prognosis of Oral Squamous Cell Carcinoma. , 2018, Anticancer research.

[11]  Hai-yan Liu,et al.  Ginseng Rh2 protects endometrial cells from oxygen glucose deprivation/re-oxygenation , 2017, Oncotarget.

[12]  R. Dumache.  Early Diagnosis of Oral Squamous Cell Carcinoma by Salivary microRNAs. , 2017, Clinical laboratory.

[13]  S. Pyne,et al.  Sphingosine 1-phosphate and cancer. , 2017, Advances in biological regulation.

[14]  B. Zhao,et al.  A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. , 2016, European heart journal.

[15]  Wei Li,et al.  Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling , 2016, Oncogene.

[16]  Wei He,et al.  MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer. , 2015, American journal of translational research.

[17]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[18]  Ye Tian,et al.  C6 ceramide dramatically enhances docetaxel-induced growth inhibition and apoptosis in cultured breast cancer cells: a mechanism study. , 2015, Experimental cell research.

[19]  Abolfazl Barzegari,et al.  MicroRNAs in colorectal cancer: from diagnosis to targeted therapy. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[20]  G. Piontek,et al.  Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk , 2014, Oncotarget.

[21]  H. Furuya,et al.  Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1 , 2014, Cancer Cell International.

[22]  Jordyn E Cleavenger,et al.  Non melanoma skin cancer review. , 2014, The Journal of the Arkansas Medical Society.

[23]  J. Chang,et al.  LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling , 2014, Oncogene.

[24]  Jin Yao,et al.  Ginsenoside Rg-1 Protects Retinal Pigment Epithelium (RPE) Cells from Cobalt Chloride (CoCl2) and Hypoxia Assaults , 2013, PloS one.

[25]  Hanwen Zhang,et al.  MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1 , 2013, Journal of Ovarian Research.

[26]  H. Furuya,et al.  The Impact of Sphingosine Kinase-1 in Head and Neck Cancer , 2013, Biomolecules.

[27]  Jiali Han,et al.  Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. , 2013, Journal of the American Academy of Dermatology.

[28]  Hong-Gang Wang,et al.  Sphingolipids: regulators of crosstalk between apoptosis and autophagy , 2013, Journal of Lipid Research.

[29]  Jintang Xia,et al.  miR‐124 inhibits cell proliferation in gastric cancer through down‐regulation of SPHK1 , 2012, The Journal of pathology.

[30]  L. Obeid,et al.  Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. , 2012, Anti-cancer agents in medicinal chemistry.

[31]  Bo Liu,et al.  MicroRNA-modulated autophagic signaling networks in cancer. , 2012, The international journal of biochemistry & cell biology.

[32]  M. Vila,et al.  Mitochondrial quality control and dynamics in Parkinson's disease. , 2012, Antioxidants & redox signaling.

[33]  S. Ponnusamy,et al.  Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. , 2010, Future oncology.

[34]  J. Gamble,et al.  The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction? , 2008, Biochimica et biophysica acta.

[35]  S. Milstien,et al.  Targeting SphK1 as a new strategy against cancer. , 2008, Current drug targets.

[36]  F. Goñi,et al.  Implication of Ceramide, Ceramide 1-Phosphate and Sphingosine 1-Phosphate in Tumorigenesis , 2008, Translational oncogenomics.

[37]  M. ter Braak,et al.  Regulation and functional roles of sphingosine kinases , 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

[38]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[39]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[40]  Min Chen,et al.  Initiator caspases in apoptosis signaling pathways , 2002, Apoptosis.

[41]  C. Garbe,et al.  Epidemiology of Skin Cancer: Update 2019. , 2020, Advances in experimental medicine and biology.

[42]  Tie Xiang,et al.  Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma. , 2018, Cellular signalling.

[43]  Y. Qiu,et al.  MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets. , 2017, Cancer biomarkers : section A of Disease markers.

[44]  Yan Zhou,et al.  MicroRNA-124 upregulation inhibits proliferation and invasion of osteosarcoma cells by targeting sphingosine kinase 1 , 2016, Human Cell.

[45]  Richard Miller,et al.  Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part II. , 2014, Journal of drugs in dermatology : JDD.

[46]  Ping Zheng,et al.  Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production , 2013, Cancer Chemotherapy and Pharmacology.

[47]  Sarah Spiegel,et al.  Sphingosine-1-phosphate signaling and its role in disease. , 2012, Trends in cell biology.